UMIN-CTR Clinical Trial

Basic information
Public title	olanzapinein the treatment of anorexia nervosa: a system review and meta-analysis
Acronym	olanzapine in anorexia nervosa
Scientific Title	olanzapine in anorexia nervosa
Scientific Title:Acronym	olanzapine in anorexia nervosa
Region	Japan Asia(except Japan)

Condition
Condition	anorexia nervosa
Classification by specialty	Medicine in general Psychiatry
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Effective of fluoxetine in anorexia nervosa
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	restore of BMI
Key secondary outcomes

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	12 years-old <=
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	AN
Key exclusion criteria	without AN
Target sample size	40

Research contact person
Name of lead principal investigator	1st name Ruijun Middle name Last name Han
Organization	Beijing Huilong guan Hospital
Division name	Beijing Huilong guan Hospital
Zip code	100096
Address	Nandian Road 7 Huilongguan, Changping district, Beijing
TEL	010-62716285
Email	bjhlgyy@163.com

Public contact
Name of contact person	1st name Ruijun Middle name Last name Han
Organization	Beijing Huilong guan Hospital
Division name	Beijing Huilong guan Hospital
Zip code	100096
Address	Nandian Road 7 Huilongguan, Changping district, Beijing
TEL	010-62716285
Homepage URL
Email	bjhlgyy@163.com

Sponsor
Institute	Beijing Huilong guan Hospital
Institute
Department

Funding Source
Organization	Beijing Huilong guan Hospital
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Beijing Huilong guan Hospital
Address	Nandian Road 7, Huilongguan, Changping district, Beijing
Tel	010-62716285
Email	bjhlgyy@163.com

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2021 Year 01 Month 30 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2021 Year 01 Month 01 Day
Date of IRB	2021 Year 01 Month 01 Day
Anticipated trial start date	2021 Year 01 Month 20 Day
Last follow-up date	2021 Year 03 Month 03 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	noe

Management information
Registered date	2021 Year 01 Month 30 Day
Last modified on	2022 Year 01 Month 10 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049289